Paracetamol, tramadol
Sold as Tramacet, Tramaspen co, Ultracet, Tramazac co, * cetromal, Synotram plus, Trampar odt, Patram, Tamoltra, Temrez, Paracetamol/tramadol cipla, Panrex, Dolotram plus, Painogesic co, Tramadol/paracetamol austell, Tramadol/paracetamol camox, Quelgez, Domadol plus, Trempamol, Cepatresic, Trampangic, Tramadol/ paracetamol ascendis
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
Background
Registration
- Applicants
- 15
- Registrations
- 23
- Schedule source
- SAHPRA documentation
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Janssen Pharmaceutica (Pty) LtdCertificate held by Janssen pharmaceutica | Tramacet, Ultracet | 37.5 mg / 25 mg, 37,5 mg/325 mg | 350010, 440931 | S5 | PIPIL |
| Pharmacare limited û woodmeadCertificate held by Pharmacare limited | Tramaspen co | 37,5 mg/325 mg | 440880 | S5 | PIPIL |
| Zydus Healthcare (Pty) LtdCertificate held by Zydus Healthcare SA (Pty) Ltd | Tramazac co, * cetromal | 37,5, 37,5 mg and 325 mg | 450303, 450304 | S5 | PIPIL |
| Cospharm Investments (Pty) Ltd | Synotram plus, Trampar odt | Not stated | 450679, 450680.679 | Not determined | None |
| Ranbaxy Pharmaceuticals (Pty) Ltd | Patram | 37,5 mg | 460449 | S5 | PIPIL |
| Pharma Dynamics (Pty) Ltd | Tamoltra | 75/650 mg, 37,5/325 mg | 460976 | S5 | PIPIL |
| Oethmaan Biosims (Pty) Ltd | Temrez, Panrex | 37.5/325 | 471053, 480447 | S5 | PIPIL |
| Cipla Medpro (Pty) LtdCancelled | Paracetamol/tramadol cipla | 325 mg/37,5 mg, 650 mg/75 mg | 480066, 480067 | Not determined | None |
| Ranbaxy Pharmaceutical (Pty) LtdCertificate held by Ranbaxy Pharmaceuticals (Pty) Ltd | Dolotram plus | 37,5 mg AND 325 mg | 480698 | S5 | PIPIL |
| Astral Pharma (Pty) Ltd | Painogesic co | Not stated | 480774 | Not determined | None |
| Austell Pharmaceuticals (Pty) Ltd | Tramadol/paracetamol austell, Tramadol/paracetamol camox | 37,5/325 mg | 491063, 491064 | Not determined | None |
| Shanur Healthcare (Pty) Ltd | Quelgez | Not stated | 491065 | Not determined | None |
| Unichem SA (Pty) Ltd | Domadol plus, Trempamol | Not stated | 540185, 540186.185 | Not determined | None |
| Biotech Laboratories (Pty) LtdCertificate held by Biotech Laboratories (Pty) Ltd. | Cepatresic, Trampangic | 37,5/325 | 560429, 560430.429 | S5 | PIPIL |
| Ascendis Pharma (Pty) Ltd | Tramadol/ paracetamol ascendis | 37,5/325 mg | 570262 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Tramacet EACH TABLET CONTAINS PARACETAMOL 325,0 mg TRAMADOL HYDROCHLORIDE 37,5 mg | 37.5 mg / 25 mgTablets | 35001035/2.9/0010Approved 1 September 2022 | Registered | S5 | PIPIL |
| Tramaspen co | 37,5 mg/325 mgFilm-coated tablets | 44088044/2.9/0880Approved 24 August 2023 | Registered | S5 | PIPIL |
| Ultracet EACH TABLET CONTAINS PARACETAMOL 325,0 mg TRAMADOL HYDROCHLORIDE 37,5 mg | 37,5 mg/325 mgFilm coated tablets | 44093144/2.9/0931Approved 1 September 2022 | Registered | S5 | PIPIL |
| Tramazac co 37,5 EACH TABLET CONTAINS PARACETAMOL 325,0 mg TRAMADOL HYDROCHLORIDE 37,5 mg | 37,5Film-coated tablets | 45030345/2.9/0303Approved 1 March 2024 | Registered | S5 | PIPIL |
| * cetromal EACH TABLET CONTAINS :PARACETAMOL 325,0 mg, TRAMADOL HYDROCHLORIDE 37,5 mg | 37,5 mg and 325 mgFilm-coated tablets. | 45030445/2.9/0304Approved 1 March 2024 | Registered | S5 | PIPIL |
| Synotram plus Each Tablet contains: Tramadol Hydrochloride 37,5 mg, Paracetamol 325,0 mg | Not listed | 45067945/2.8/0679 | Registered | Not determined | None |
| Trampar odt Each Tablet contains: Tramadol Hydrochloride 37,5 mg, Paracetamol 325,0 mg | Not listed | 450680.67945/2.8/0680.679 | Registered | Not determined | None |
| Patram EACH TABLET CONTAINS PARACETAMOL 325,0 mg, TRAMADOL HYDROCHLORIDE 37,5 mg | 37,5 mgFilm-coated tablets. | 46044946/2.9/0449Approved 4 February 2026 | Registered | S5 | PIPIL |
| Tamoltra EACH TABLET CONTAINS PARACETAMOL 325,0 mg TRAMADOL HYDROCHLORIDE 37,5 mg | 75/650 mg, 37,5/325 mgFilm-coated tablets. | 46097646/2.9/0976Approved 27 February 2025 | Registered | S5 | PIPIL |
| Temrez 37.5/325 Each Film coated Tablet contains: Tramadol Hydrochloride 37,5 mg, Paracetamol 325,0 mg | 37.5/325Film-coated tablets. | 47105347/2.9/1053Approved 16 August 2023 | Registered | S5 | PIPIL |
| Paracetamol/tramadol 325 mg/37,5 MG cipla EACH TABLET CONTAINS : PARACETAMOL 325,0 mg TRAMADOL HYDROCHLORIDE 37,5 mg | 325 mg/37,5 mg | 48006648/2.9/0066 | Cancelled | Not determined | None |
| Paracetamol/tramadol 650 mg/75 MG cipla EACH TABLET CONTAINS : PARACETAMOL 650,0 mg TRAMADOL HYDROCHLORIDE 75,0 mg | 650 mg/75 mg | 48006748/2.9/0067 | Cancelled | Not determined | None |
| Panrex 37.5/325 Each Film coated Tablet contains: Tramadol Hydrochloride 37,5 mg, Paracetamol 325,0 mg | 37.5/325Film-coated tablets. | 48044748/2.9/0447Approved 16 August 2023 | Registered | S5 | PIPIL |
| Dolotram plus EACH TABLET CONTAINS: TRAMADOL HYDROCHLORIDE 37,5 mg PARACETAMOL 325,0 mg | 37,5 mg AND 325 mgFilm-coated tablets. | 48069848/2.9/0698Approved 22 August 2025 | Registered | S5 | PIPIL |
| Painogesic co Each Tablet contains: Tramadol Hydrochloride 37,5 mg, Paracetamol 325,0 mg | Not listed | 48077448/2.9/0774 | Registered | Not determined | None |
| Tramadol/paracetamol 37,5/325 MG austell EACH TABLET CONTAINS: TRAMADOL HYDROCHLORIDE 37,5 mg PARACETAMOL 325,0 mg | 37,5/325 mg | 49106349/2.9/1063 | Registered | Not determined | None |
| Tramadol/paracetamol 37,5/325 MG camox EACH TABLET CONTAINS: TRAMADOL HYDROCHLORIDE 37,5 mg PARACETAMOL 325,0 mg | 37,5/325 mg | 49106449/2.9/1064 | Registered | Not determined | None |
| Quelgez Each Tablet contains: Tramadol Hydrochloride 37,5 mg ; Paracetamol 325,0 mg | Not listed | 49106549/2.9/1065 | Registered | Not determined | None |
| Domadol plus EACH TABLET CONTAINS TRAMADOL HYDROCHLORIDE 37,5,0 mg PARACETAMOL 325,0 mg | Not listed | 54018554/2.9/0185 | Registered | Not determined | None |
| Trempamol EACH TABLET CONTAINS TRAMADOL HYDROCHLORIDE 37,5,0 mg PARACETAMOL 325,0 mg | Not listed | 540186.18554/2.9/0186.185 | Registered | Not determined | None |
| Cepatresic 37,5/325 EACH TABLET CONTAINS TRAMADOL HYDROCHLORIDE 37,5 mg PARACETAMOL 325,0 mg | 37,5/325Film-coated tablets | 56042956/2.9/0429Approved 23 April 2024 | Registered | S5 | PIPIL |
| Trampangic 37,5/325 EACH TABLET CONTAINS TRAMADOL HYDROCHLORIDE 37,5,0 mg PARACETAMOL 325,0 mg | 37,5/325Film-coated tablets | 560430.42956/2.9/0430.429Approved 23 April 2024 | Registered | S5 | PIPIL |
| Tramadol/ paracetamol 37,5/325 MG ascendis EACH TABLET CONTAINS: TRAMADOL HYDROCHLORIDE 37,5 mg PARACETAMOL 325,0 mg | 37,5/325 mg | 57026257/2.9/0262 | Registered | Not determined | None |
Regulatory status
Where S5 sits on the scale
Prescription-only, with tighter controls on repeats.
Schedule 5 medicines need a prescription, and repeat dispensing is capped at six months in total; the prescriber must state upfront how many times, and at what intervals, it may be repeated. Extra limits apply to some uses: if it is being used for its anxiolytic, antidepressant, tranquillising or analgesic properties, it cannot be prescribed for longer than six months without a further consultation. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S5, read from the product's PI-PIL leaflet.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it.
Consolidated Schedules listings for Paracetamol, tramadol hydrochloride
S5: Tramadol
Consolidated Schedules 06 July 2026, line 9725
S3: Paracetamol
- when intended for injection.
Consolidated Schedules 06 July 2026, line 4093
S2: Paracetamol
- when contained in rectal suppositories, or
- when contained in modified release formulations. (S0, S1, S3)
Consolidated Schedules 06 July 2026, lines 2496 to 2500
S1: Paracetamol
- immediate release tablets or capsules each containing 500 milligrams or less of paracetamol, or in individually wrapped powders or in sachets containing 1 000 milligrams or less of paracetamol, subject to - (i) a maximum of 12,5 grams of paracetamol per primary pack, and (ii) in the case of tablets or capsules, presented in blister strip packaging or in containers with child-resistant closures; and (iii) labelled with the following boxed warning, placed prominently on at least the main panel of the immediate container label and outer label (carton): “CONTAINS PARACETAMOL - READ THE PACKAGE INSERT”; (S0)
- in liquid or syrup dosage form containing 120 milligrams or less of paracetamol per 5 millilitres or in paediatric drops containing 120 milligrams or less of paracetamol per 1,2 millilitres, subject to - (i) a maximum of 100 millilitres per primary pack in the case of the liquid or syrup dosage form containing 120 milligrams or less of paracetamol per 5 millilitres; (ii) a maximum of 20 millilitres per primary pack in the case of the paediatric drops; (iii) labelled with the following boxed warning, placed prominently on at least the main panel of the immediate container label and outer label (carton): “CONTAINS PARACETAMOL - READ THE PACKAGE INSERT”; (S0)
- when contained in rectal suppositories. (S2)
- when contained in modified release formulations. (S2)
- when intended for injection. (S3)
Consolidated Schedules 06 July 2026, lines 958 to 997
Pharmacological class: Other analgesics. (class 2.9)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Tramacet, Janssen Pharmaceutica (Pty) Ltd is scheduled S5 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.